Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Emerging Treatments and Technologies

The Treat-to-Target Trial

Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

  1. Matthew C. Riddle, MD1,
  2. Julio Rosenstock, MD2,
  3. John Gerich, MD3 and
  4. on behalf of the Insulin Glargine 4002 Study Investigators*
  1. 1Oregon Health and Science University, Portland, Oregon
  2. 2Dallas Diabetes and Endocrine Center, Dallas, Texas
  3. 3University of Rochester Medical Center, Rochester, New York
  1. Address correspondence and reprint requests to Matthew C. Riddle, MD, Oregon Health and Science University, Section of Diabetes L-345, 3181 S.W. Sam Jackson, Portland, OR 97201. E-mail: riddlem{at}ohsu.edu
Diabetes Care 2003 Nov; 26(11): 3080-3086. https://doi.org/10.2337/diacare.26.11.3080
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 26 no. 11 3080-3086
DOI 
https://doi.org/10.2337/diacare.26.11.3080
PubMed 
14578243

Published By 
American Diabetes Association
Print ISSN 
0149-5992
Online ISSN 
1935-5548
History 
  • July 23, 2003
  • February 18, 2003
  • Published in print October 24, 2003.

Copyright & Usage 
DIABETES CARE

Author Information

  1. Matthew C. Riddle, MD1,
  2. Julio Rosenstock, MD2,
  3. John Gerich, MD3 and
  4. on behalf of the Insulin Glargine 4002 Study Investigators*
  1. 1Oregon Health and Science University, Portland, Oregon
  2. 2Dallas Diabetes and Endocrine Center, Dallas, Texas
  3. 3University of Rochester Medical Center, Rochester, New York
  1. Address correspondence and reprint requests to Matthew C. Riddle, MD, Oregon Health and Science University, Section of Diabetes L-345, 3181 S.W. Sam Jackson, Portland, OR 97201. E-mail: riddlem{at}ohsu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2003 to March 2021

Rendering graph...
AbstractFullPdf
Oct 2003362516433
Nov 20034301018629
Dec 2003146302185
Jan 2004104295155
Feb 200486215117
Mar 2004121305156
Apr 200481203112
May 200448176196
Jun 200469220211
Jul 200456188208
Aug 200457204231
Sep 200467232302
Oct 200490219263
Nov 200485277257
Dec 200472209143
Jan 2005171211262
Feb 2005108235268
Mar 2005139305341
Apr 200598236270
May 2005106273286
Jun 2005115243243
Jul 200577163209
Aug 2005149207282
Sep 2005128202210
Oct 2005150236243
Nov 2005126243289
Dec 200589196197
Jan 2006125239251
Feb 2006144249232
Mar 2006137256284
Apr 2006137244258
May 2006143230228
Jun 200692204204
Jul 2006105210204
Aug 2006116174177
Sep 2006132209209
Oct 2006131262258
Nov 2006130200187
Dec 200666137127
Jan 2007113144189
Feb 2007120181197
Mar 2007181339258
Apr 2007128228184
May 2007144172208
Jun 2007117190209
Jul 2007125148185
Aug 2007114173215
Sep 2007201173253
Oct 2007246265339
Nov 2007194242289
Dec 2007122124149
Jan 2008248228303
Feb 2008250251305
Mar 2008259220280
Apr 2008196176224
May 2008156145202
Jun 2008181151213
Jul 2008152159199
Aug 2008127122171
Sep 2008209147225
Oct 2008161169204
Nov 2008153152208
Dec 20089784129
Jan 2009120116161
Feb 2009146120169
Mar 2009210185250
Apr 2009142137208
May 20098967111
Jun 200917483100
Jul 2009279163169
Aug 200921010093
Sep 2009349136152
Oct 2009290163165
Nov 2009275168173
Dec 2009197136179
Jan 2010247113221
Feb 201022698106
Mar 2010248107149
Apr 2010253144134
May 2010239161140
Jun 2010238159151
Jul 2010245140141
Aug 2010243161161
Sep 2010227152152
Oct 2010239178162
Nov 2010242125120
Dec 201020099111
Jan 2011237178171
Feb 2011277179165
Mar 2011297183159
Apr 2011256219183
May 2011269153182
Jun 2011250146141
Jul 2011226136128
Aug 2011226122152
Sep 2011351166216
Oct 2011296173217
Nov 2011303189205
Dec 2011196120124
Jan 2012287176177
Feb 2012256151151
Mar 2012308174190
Apr 2012303154184
May 2012270182200
Jun 2012252126148
Jul 2012188175159
Aug 2012248179162
Sep 2012365182199
Oct 2012381295253
Nov 2012297257201
Dec 2012212197137
Jan 2013310288216
Feb 2013293257214
Mar 2013282239219
Apr 2013271224230
May 2013281270365
Jun 2013137119287
Jul 2013189210249
Aug 2013250270226
Sep 2013355310238
Oct 2013370268237
Nov 2013366329224
Dec 2013213201181
Jan 2014254203181
Feb 2014308204218
Mar 2014343297337
Apr 2014399240290
May 2014368245241
Jun 2014278205249
Jul 2014357170187
Aug 2014329173225
Sep 2014314226206
Oct 2014349186183
Nov 2014323159190
Dec 2014204166118
Jan 2015225196147
Feb 2015286171152
Mar 2015334254187
Apr 2015347281208
May 2015291194224
Jun 2015323203251
Jul 2015257192239
Aug 2015239192209
Sep 2015347246228
Oct 2015348232223
Nov 2015253206174
Dec 2015239156163
Jan 2016315234131
Feb 2016237303187
Mar 2016480313196
Apr 2016270275135
May 2016207551148
Jun 2016129390147
Jul 2016127397165
Aug 2016139418153
Sep 2016146516182
Oct 2016204466160
Nov 2016205418210
Dec 2016106289161
Jan 201792447113
Feb 201734432140
Mar 201743414187
Apr 201737243117
May 201734285124
Jun 20172325896
Jul 201713269106
Aug 2017823891
Sep 20179241101
Oct 201710414102
Nov 201710374133
Dec 20171227675
Jan 201821326129
Feb 201858318128
Mar 201881317124
Apr 20183726884
May 201856287125
Jun 201841310100
Jul 20185227796
Aug 201834252102
Sep 201845316107
Oct 201861336104
Nov 20187433080
Dec 20185523798
Jan 20195632795
Feb 201952355150
Mar 201962378104
Apr 201940456146
May 201942420115
Jun 201925364100
Jul 201916479120
Aug 2019465584
Sep 201931020100
Oct 20194791129
Nov 2019455299
Dec 2019239573
Jan 2020639556
Feb 2020342792
Mar 20203404112
Apr 2020327063
May 2020735490
Jun 2020724462
Jul 20202339190
Aug 20202430282
Sep 20202531881
Oct 202031369108
Nov 20202135990
Dec 20202535068
Jan 20213639974
Feb 20212437167
Mar 20213145

PreviousNext
Back to top
Diabetes Care: 26 (11)

In this Issue

November 2003, 26(11)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Treat-to-Target Trial
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Treat-to-Target Trial
Matthew C. Riddle, Julio Rosenstock, John Gerich
Diabetes Care Nov 2003, 26 (11) 3080-3086; DOI: 10.2337/diacare.26.11.3080

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

The Treat-to-Target Trial
Matthew C. Riddle, Julio Rosenstock, John Gerich
Diabetes Care Nov 2003, 26 (11) 3080-3086; DOI: 10.2337/diacare.26.11.3080
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • APPENDIX
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
  • Autologous Umbilical Cord Blood Transfusion in Young Children With Type 1 Diabetes Fails to Preserve C-Peptide
  • Diabetes Antibody Standardization Program
Show more Emerging Treatments and Technologies

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.